Detalles de la búsqueda
1.
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.
Rheumatology (Oxford)
; 59(2): 398-406, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359048
2.
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 59(7): 1715-1724, 2020 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31774531
3.
Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study.
Adv Ther
; 39(11): 5259-5273, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136243
4.
Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.
J Clin Lipidol
; 11(4): 929-937, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28647412
5.
Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
J Womens Health (Larchmt)
; 25(7): 697-706, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26889924
6.
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.
Curr Med Res Opin
; 21(5): 715-22, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15974563
7.
Postponed development of disability in elderly runners: a 13-year longitudinal study.
Arch Intern Med
; 162(20): 2285-94, 2002 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-12418943
8.
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Clin Ther
; 37(4): 804-15, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25626487
9.
Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
Vasc Health Risk Manag
; 10: 237-46, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24851051
10.
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
J Clin Lipidol
; 8(1): 107-16, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24528691
11.
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
Vasc Health Risk Manag
; 9: 719-27, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24265554
12.
Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting.
J Clin Lipidol
; 7(5): 399-407, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24079280
13.
A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.
Circ Cardiovasc Genet
; 4(6): 595-604, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22010137
14.
Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.
J Clin Lipidol
; 4(6): 491-500, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21122696
15.
Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients.
J Clin Lipidol
; 4(2): 126-32, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21122640
16.
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.
Curr Med Res Opin
; 24(1): 249-59, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18053317
17.
Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study.
Nutr Metab Cardiovasc Dis
; 16(1): 13-21, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16399487
Resultados
1 -
17
de 17
1
Próxima >
>>